Startup aims to make genomics data clinically useful

02/21/2013 | Xconomy

Silicon Valley Biosystems, or simply SV Bio, joins InVitae, Caris Life Sciences and Foundation Medicine in developing methods for translating genomics data into clinically useful information. The company plans to create a network of labs to take samples, examine broad genomic regions, decode the data and send the results to doctors within a few days. "The coming age of the $1,000 genome has made it possible for physicians to start thinking about whether it's practical to do broader sequencing runs for routine diagnostic purposes," writes Luke Timmerman.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI